| Barnes Home Health Care, Inc | |
| 10820 E 45th St, Ste 301, Tulsa, Oklahoma 74146 | |
| (918) 610-0089 | |
| Name | Barnes Home Health Care, Inc |
|---|---|
| Location | 10820 E 45th St, Ste 301, Tulsa, Oklahoma |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 377471 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 74006, 74008, 74012, 74014, 74015, 74021, 74033, 74037, 74047, 74055, 74063, 74066, 74067, 74104, 74105, 74106, 74107, 74110, 74112, 74114, 74115, 74119, 74120, 74127, 74128, 74129, 74130, 74132, 74133, 74134, 74135, 74136, 74137, 74145, 74146, 74421, 74436 |
| NPI Number | 1821091281 |
| Organization Name | BARNES HOME HEALTH CARE, INC. |
| Address | 10820 E 45th St, Ste 301, Tulsa, OK 74146 |
| Phone Number | 918-610-0089 |
News Archive
"Grand Challenges Canada on Thursday announced 15 grants valued in total at more than $1.5 million awarded to some of Canada's most creative innovators from across the country in support of their work to improve global health conditions," according to a press release from the Sandra Rotman Centre for Global Health, which hosts Grand Challenges.
GTx, Inc. (Nasdaq: GTXI) today reported financial results for the second quarter of 2009. The net loss for the second quarter and six months ended June 30, 2009 was $11.3 million and $22.6 million, respectively, compared with a net loss of $13.2 million and $26.0 million for the same periods in 2008. At June 30, 2009 GTx had cash, cash equivalents and short-term investments of $68.9 million.
Idera Pharmaceuticals today announced that 48% of patients with moderate-to-severe plaque psoriasis (12 of 25) treated with IMO-3100, a selective antagonist of Toll-like Receptors (TLRs) 7 and 9, demonstrated improvements in Psoriasis Area Severity Index (PASI) scores of 35% to 90% from baseline at the completion of a randomized, double-blind, placebo-controlled Phase 2a clinical trial of two dose levels of IMO-3100 administered for four weeks, with a four-week follow-up period.
Cancer Research UK scientists have discovered that a common gene fault in cervical cancer cells triggers a ripple of molecular signals - which makes the disease more aggressive, according to research published in The Journal of Pathology.
The coronavirus disease (COVID-19) outbreak, which started in Wuhan, in Hubei province in China, now has nearly 1,700 deaths and more than 69,000 infections. The majority of the infections and deaths are in mainland China but has started to spread across 25 countries. Are these numbers alarming?
› Verified 1 days ago
| Quality Rating: |
News Archive
"Grand Challenges Canada on Thursday announced 15 grants valued in total at more than $1.5 million awarded to some of Canada's most creative innovators from across the country in support of their work to improve global health conditions," according to a press release from the Sandra Rotman Centre for Global Health, which hosts Grand Challenges.
GTx, Inc. (Nasdaq: GTXI) today reported financial results for the second quarter of 2009. The net loss for the second quarter and six months ended June 30, 2009 was $11.3 million and $22.6 million, respectively, compared with a net loss of $13.2 million and $26.0 million for the same periods in 2008. At June 30, 2009 GTx had cash, cash equivalents and short-term investments of $68.9 million.
Idera Pharmaceuticals today announced that 48% of patients with moderate-to-severe plaque psoriasis (12 of 25) treated with IMO-3100, a selective antagonist of Toll-like Receptors (TLRs) 7 and 9, demonstrated improvements in Psoriasis Area Severity Index (PASI) scores of 35% to 90% from baseline at the completion of a randomized, double-blind, placebo-controlled Phase 2a clinical trial of two dose levels of IMO-3100 administered for four weeks, with a four-week follow-up period.
Cancer Research UK scientists have discovered that a common gene fault in cervical cancer cells triggers a ripple of molecular signals - which makes the disease more aggressive, according to research published in The Journal of Pathology.
The coronavirus disease (COVID-19) outbreak, which started in Wuhan, in Hubei province in China, now has nearly 1,700 deaths and more than 69,000 infections. The majority of the infections and deaths are in mainland China but has started to spread across 25 countries. Are these numbers alarming?
› Verified 1 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 96.4 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 100 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 93.8 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 97.2 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 97.2 | 96.4 |
News Archive
"Grand Challenges Canada on Thursday announced 15 grants valued in total at more than $1.5 million awarded to some of Canada's most creative innovators from across the country in support of their work to improve global health conditions," according to a press release from the Sandra Rotman Centre for Global Health, which hosts Grand Challenges.
GTx, Inc. (Nasdaq: GTXI) today reported financial results for the second quarter of 2009. The net loss for the second quarter and six months ended June 30, 2009 was $11.3 million and $22.6 million, respectively, compared with a net loss of $13.2 million and $26.0 million for the same periods in 2008. At June 30, 2009 GTx had cash, cash equivalents and short-term investments of $68.9 million.
Idera Pharmaceuticals today announced that 48% of patients with moderate-to-severe plaque psoriasis (12 of 25) treated with IMO-3100, a selective antagonist of Toll-like Receptors (TLRs) 7 and 9, demonstrated improvements in Psoriasis Area Severity Index (PASI) scores of 35% to 90% from baseline at the completion of a randomized, double-blind, placebo-controlled Phase 2a clinical trial of two dose levels of IMO-3100 administered for four weeks, with a four-week follow-up period.
Cancer Research UK scientists have discovered that a common gene fault in cervical cancer cells triggers a ripple of molecular signals - which makes the disease more aggressive, according to research published in The Journal of Pathology.
The coronavirus disease (COVID-19) outbreak, which started in Wuhan, in Hubei province in China, now has nearly 1,700 deaths and more than 69,000 infections. The majority of the infections and deaths are in mainland China but has started to spread across 25 countries. Are these numbers alarming?
› Verified 1 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 80.7 | 79.6 |
| How often patients got better at getting in and out of bed | 73.3 | 81.1 |
| How often patients got better at bathing | 84.1 | 82.3 |
| How often patients’ breathing improved | 89.3 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 73 | 75 |
| How often home health patients had to be admitted to the hospital | 17.1 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 15.8 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 94.5 | 94 |
News Archive
"Grand Challenges Canada on Thursday announced 15 grants valued in total at more than $1.5 million awarded to some of Canada's most creative innovators from across the country in support of their work to improve global health conditions," according to a press release from the Sandra Rotman Centre for Global Health, which hosts Grand Challenges.
GTx, Inc. (Nasdaq: GTXI) today reported financial results for the second quarter of 2009. The net loss for the second quarter and six months ended June 30, 2009 was $11.3 million and $22.6 million, respectively, compared with a net loss of $13.2 million and $26.0 million for the same periods in 2008. At June 30, 2009 GTx had cash, cash equivalents and short-term investments of $68.9 million.
Idera Pharmaceuticals today announced that 48% of patients with moderate-to-severe plaque psoriasis (12 of 25) treated with IMO-3100, a selective antagonist of Toll-like Receptors (TLRs) 7 and 9, demonstrated improvements in Psoriasis Area Severity Index (PASI) scores of 35% to 90% from baseline at the completion of a randomized, double-blind, placebo-controlled Phase 2a clinical trial of two dose levels of IMO-3100 administered for four weeks, with a four-week follow-up period.
Cancer Research UK scientists have discovered that a common gene fault in cervical cancer cells triggers a ripple of molecular signals - which makes the disease more aggressive, according to research published in The Journal of Pathology.
The coronavirus disease (COVID-19) outbreak, which started in Wuhan, in Hubei province in China, now has nearly 1,700 deaths and more than 69,000 infections. The majority of the infections and deaths are in mainland China but has started to spread across 25 countries. Are these numbers alarming?
› Verified 1 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
"Grand Challenges Canada on Thursday announced 15 grants valued in total at more than $1.5 million awarded to some of Canada's most creative innovators from across the country in support of their work to improve global health conditions," according to a press release from the Sandra Rotman Centre for Global Health, which hosts Grand Challenges.
GTx, Inc. (Nasdaq: GTXI) today reported financial results for the second quarter of 2009. The net loss for the second quarter and six months ended June 30, 2009 was $11.3 million and $22.6 million, respectively, compared with a net loss of $13.2 million and $26.0 million for the same periods in 2008. At June 30, 2009 GTx had cash, cash equivalents and short-term investments of $68.9 million.
Idera Pharmaceuticals today announced that 48% of patients with moderate-to-severe plaque psoriasis (12 of 25) treated with IMO-3100, a selective antagonist of Toll-like Receptors (TLRs) 7 and 9, demonstrated improvements in Psoriasis Area Severity Index (PASI) scores of 35% to 90% from baseline at the completion of a randomized, double-blind, placebo-controlled Phase 2a clinical trial of two dose levels of IMO-3100 administered for four weeks, with a four-week follow-up period.
Cancer Research UK scientists have discovered that a common gene fault in cervical cancer cells triggers a ripple of molecular signals - which makes the disease more aggressive, according to research published in The Journal of Pathology.
The coronavirus disease (COVID-19) outbreak, which started in Wuhan, in Hubei province in China, now has nearly 1,700 deaths and more than 69,000 infections. The majority of the infections and deaths are in mainland China but has started to spread across 25 countries. Are these numbers alarming?
› Verified 1 days ago
The patient survey data of Barnes Home Health Care, Inc is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 91 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 93 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 87 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 94 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 89 | 78 |
News Archive
"Grand Challenges Canada on Thursday announced 15 grants valued in total at more than $1.5 million awarded to some of Canada's most creative innovators from across the country in support of their work to improve global health conditions," according to a press release from the Sandra Rotman Centre for Global Health, which hosts Grand Challenges.
GTx, Inc. (Nasdaq: GTXI) today reported financial results for the second quarter of 2009. The net loss for the second quarter and six months ended June 30, 2009 was $11.3 million and $22.6 million, respectively, compared with a net loss of $13.2 million and $26.0 million for the same periods in 2008. At June 30, 2009 GTx had cash, cash equivalents and short-term investments of $68.9 million.
Idera Pharmaceuticals today announced that 48% of patients with moderate-to-severe plaque psoriasis (12 of 25) treated with IMO-3100, a selective antagonist of Toll-like Receptors (TLRs) 7 and 9, demonstrated improvements in Psoriasis Area Severity Index (PASI) scores of 35% to 90% from baseline at the completion of a randomized, double-blind, placebo-controlled Phase 2a clinical trial of two dose levels of IMO-3100 administered for four weeks, with a four-week follow-up period.
Cancer Research UK scientists have discovered that a common gene fault in cervical cancer cells triggers a ripple of molecular signals - which makes the disease more aggressive, according to research published in The Journal of Pathology.
The coronavirus disease (COVID-19) outbreak, which started in Wuhan, in Hubei province in China, now has nearly 1,700 deaths and more than 69,000 infections. The majority of the infections and deaths are in mainland China but has started to spread across 25 countries. Are these numbers alarming?
› Verified 1 days ago
Hillcrest Regional Home Health South Location: 7600 South Lewis Ave, Tulsa, Oklahoma 74136 Ratings: NA Phone: (918) 579-7842 | |
St John Home Care, Llc Location: 4720 South Harvard, Suite 202, Tulsa, Oklahoma 74135 Ratings: Phone: (918) 747-7901 | |
Saint Francis Home Health Location: 6600 S Yale Ave, Ste 200, Tulsa, Oklahoma 74136 Ratings: Phone: (918) 488-6888 | |
Live Well Home Care, Llc Location: 8165 S Mingo Road, Suite 102, Tulsa, Oklahoma 74133 Ratings: NA Phone: (918) 710-5103 | |
Interim Healthcare Of Tulsa Location: 2828 East 51st Street, Ste 102, Tulsa, Oklahoma 74105 Ratings: Phone: (918) 749-9933 | |
Kindred At Home Iii Location: 5314 South Yale, Suite 500, Tulsa, Oklahoma 74135 Ratings: NA Phone: (918) 488-6153 |